Axon Enterprise (NASDAQ:AXON) Shares Gap Down to $327.64

Axon Enterprise, Inc. (NASDAQ:AXONGet Free Report) gapped down before the market opened on Tuesday . The stock had previously closed at $327.64, but opened at $312.82. Axon Enterprise shares last traded at $311.00, with a volume of 195,069 shares trading hands.

Wall Street Analyst Weigh In

Several analysts recently issued reports on the stock. The Goldman Sachs Group boosted their target price on shares of Axon Enterprise from $297.00 to $339.00 and gave the company a “buy” rating in a research report on Wednesday, February 28th. JMP Securities reissued a “market outperform” rating and set a $375.00 price target on shares of Axon Enterprise in a report on Tuesday. StockNews.com cut Axon Enterprise from a “buy” rating to a “hold” rating in a research report on Thursday, March 14th. William Blair restated an “outperform” rating on shares of Axon Enterprise in a research note on Wednesday, April 24th. Finally, Robert W. Baird increased their price objective on shares of Axon Enterprise from $260.00 to $300.00 and gave the stock an “outperform” rating in a research note on Thursday, February 22nd. Two investment analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. According to MarketBeat.com, Axon Enterprise presently has a consensus rating of “Moderate Buy” and an average target price of $333.08.

Get Our Latest Report on AXON

Axon Enterprise Stock Performance

The stock has a market capitalization of $23.32 billion, a PE ratio of 91.19 and a beta of 0.91. The business’s fifty day moving average is $310.82 and its two-hundred day moving average is $267.44. The company has a quick ratio of 2.66, a current ratio of 3.00 and a debt-to-equity ratio of 0.42.

Axon Enterprise (NASDAQ:AXONGet Free Report) last posted its earnings results on Monday, May 6th. The biotechnology company reported $1.15 earnings per share for the quarter, topping analysts’ consensus estimates of $0.95 by $0.20. Axon Enterprise had a net margin of 11.14% and a return on equity of 14.11%. The firm had revenue of $460.74 million for the quarter, compared to the consensus estimate of $441.57 million. The business’s quarterly revenue was up 34.3% on a year-over-year basis. During the same period in the previous year, the firm posted $0.51 EPS. As a group, research analysts anticipate that Axon Enterprise, Inc. will post 2.44 EPS for the current fiscal year.

Hedge Funds Weigh In On Axon Enterprise

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Avantax Advisory Services Inc. raised its stake in shares of Axon Enterprise by 0.8% in the first quarter. Avantax Advisory Services Inc. now owns 5,302 shares of the biotechnology company’s stock valued at $1,659,000 after acquiring an additional 40 shares during the period. Brookstone Capital Management boosted its position in shares of Axon Enterprise by 5.1% during the first quarter. Brookstone Capital Management now owns 839 shares of the biotechnology company’s stock valued at $263,000 after buying an additional 41 shares during the period. HB Wealth Management LLC grew its stake in shares of Axon Enterprise by 3.9% during the fourth quarter. HB Wealth Management LLC now owns 1,139 shares of the biotechnology company’s stock valued at $294,000 after buying an additional 43 shares during the last quarter. Envestnet Portfolio Solutions Inc. lifted its stake in shares of Axon Enterprise by 1.1% during the 4th quarter. Envestnet Portfolio Solutions Inc. now owns 3,997 shares of the biotechnology company’s stock worth $1,033,000 after acquiring an additional 43 shares during the last quarter. Finally, UMB Bank n.a. boosted its holdings in Axon Enterprise by 11.0% during the 4th quarter. UMB Bank n.a. now owns 444 shares of the biotechnology company’s stock valued at $115,000 after acquiring an additional 44 shares during the period. Hedge funds and other institutional investors own 79.08% of the company’s stock.

About Axon Enterprise

(Get Free Report)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Recommended Stories

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.